Editorial

DOI: 10.4244/EIJ-E-24-00006

The miracle of left ventricular recovery after transcatheter aortic valve implantation

Harold L. Dauerman1, MD; Rony Lahoud1, MD, MPH

In this issue of EuroIntervention, Witberg et al1 analyse data from the AMTRAC Registry to examine the incidence, predictors and outcomes of left ventricular (LV) recovery post-transcatheter aortic valve implantation (TAVI). Of 10,872 TAVI patients included in this 17-centre registry from Europe and Israel, 914 had severe LV dysfunction prior to TAVI (LV ejection fraction [LVEF] ≤30%). LVEF recovered by ≥10% in 59.5% of patients and normalised to ≥50% in approximately one-quarter of patients. Compared to patients with a baseline LVEF >30%, no LV recovery was associated with increased mortality, LV recovery with similar mortality, and LV normalisation with lower mortality at 3 years. The miraculous nature of these results deserves further examination.

While it may seem obvious that unloading the ventricle with an aortic intervention would lead to early imprÂoÂvÂeÂÂÂÂÂments in LV systolic function, these findings should not be taken for granted. For example, it also seems obvious that revascularisation of multivessel coronary artery disease (CAD) should improve LV systolic function in patients with ischaemic cardiomyopathy. Yet, revascularisation with either percutaneous coronary intervention (PCI) or coronary artery bypass...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 20 Number 8
Apr 15, 2024
Volume 20 Number 8
View full issue


Key metrics

Suggested by Cory

Original Research

10.4244/EIJ-D-24-00442 Nov 18, 2024
Long-term survival after TAVI in low-flow, low-gradient aortic valve stenosis
Cardaioli F et al

10.4244/EIJV10I7A134 Nov 20, 2014
Low-flow, low-gradient aortic stenosis: should TAVI be the default therapeutic option?
O’Sullivan C and Wenaweser P
free

Editorial

10.4244/EIJ-E-23-00054 Dec 4, 2023
Cardiac damage staging in the flow-gradient patterns of aortic stenosis
Pibarot P and Tastet L
free
Trending articles
225.68

State-of-the-Art Review

10.4244/EIJ-D-21-00426 Dec 3, 2021
Myocardial infarction with non-obstructive coronary artery disease
Lindahl B et al
free
105.78

Expert consensus

10.4244/EIJ-E-22-00018 Dec 4, 2023
Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations
Lunardi M et al
free
77.85

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
68.7

Clinical research

10.4244/EIJ-D-21-00545 Sep 20, 2022
Coronary lithotripsy for the treatment of underexpanded stents: the international; multicentre CRUNCH registry
Tovar Forero M et al
free
47.8

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
45.3

Clinical research

10.4244/EIJ-D-18-01126 Aug 29, 2019
New-generation mechanical circulatory support during high-risk PCI: a cross-sectional analysis
Ameloot K et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved